Cited by 403Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and PostpartumPrenatal Substance Exposure Effects

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Use of antidepressant medications during pregnancy: a multisite study

Andrade, Susan E., Raebel, Marsha A., Brown, Jeffrey, Lane, Kimberly, Livingston, James, Boudreau, Denise, Rolnick, Sharon J., Roblin, Douglas, Smith, David H., Willy, Mary E., Staffa, Judy A., Platt, Richard·2008·American Journal of Obstetrics and Gynecology

DOI 10.1016/j.ajog.2007.07.036

Open this paper in CoChat — free account

Abstract

Objective This study was undertaken to provide information on the prevalence of use of antidepressant drugs among pregnant women in the United States.Study design A retrospective study was conducted using the automated databases of 7 health plans. Women who delivered an infant in a hospital were identified. Antidepressant drug use was evaluated assuming a gestational duration of 270 days.Results Among the 118,935 deliveries occurring from 2001-2005, 6.6% of women were dispensed an antidepressant during pregnancy. Antidepressant drug use increased from 2.0% in 1996 to 7.6% of deliveries in 2004 and 2005. Selective serotonin reuptake inhibitor use increased from 1.5% in 1996 to 6.4% in 2004 and 6.2% in 2005.Conclusion Our finding that nearly 8% of pregnant women were prescribed antidepressants drugs during the years 2004 and 2005 highlights the importance of understanding the effects of these medications on the developing fetus and on the pregnant woman.

Integrity signals

Registry

Crossref · 10.1016/j.ajog.2007.07.036

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C., Hernández–Dı́az, S., Marter, L. J. V., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 877
Depressive Symptoms among Pregnant Women Screened in Obstetrics Settings
Marcus, S. M., Flynn, H. A., Blow, F. C., & Barry, K. L. (2003) · Journal of Women's Health · doi:10.1089/154099903765448880 · Cited by 742
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735
Prescription drug use in pregnancy
Andrade, S. E., Gurwitz, J. H., Davis, R. L., Chan, K. A., Finkelstein, J. A., Fortman, K. K., McPhillips, H. A., Raebel, M. A., Roblin, D. W., Smith, D. H., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.025 · Cited by 562
Perinatal Risks of Untreated Depression during Pregnancy
Bonari, L., Pinto, N., Ahn, E., Einarson, A., Steiner, M. S., & Koren, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901103 · Cited by 534
Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors
Moses‐Kolko, E. L., Bogen, D. L., Perel, J. M., Bregar, A. J., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 532
Pharmacoepidemiology
(2006) · Wiley eBooks · doi:10.1002/9780470059876 · Cited by 342
Neonatal Abstinence Syndrome After In Utero Exposure to Selective Serotonin Reuptake Inhibitors in Term Infants
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329

Show all 18 references

Research works printed but not linked: 2

2006, Paxil and the risk of birth defects, FDA Consumer, 40, 4
Alwan, 2005, Maternal use of selective serotonin re-uptake inhibitors and risk for birth defects, Birth Defects Res A Clin Mol Teratol, 73, 291

Sorted by citations

Items 101–200 of 402

Does Paroxetine Cause Cardiac Malformations?
O’Brien, L., Einarson, T. R., Sarkar, M., Einarson, A., & Koren, G. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32918-8 · Cited by 56
Serotonin-estrogen interactions: What can we learn from pregnancy?
Thibeault, A.-A. H., Sanderson, J. T., & Vaillancourt, C. (2019) · Biochimie · doi:10.1016/j.biochi.2019.03.023 · Cited by 56
Developmental Outcomes of Children Exposed to Antidepressants in Pregnancy
Galbally, M., Lewis, A. J., & Buist, A. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.549995 · Cited by 56
On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants:The Prenatal Antidepressant Exposure Syndrome
Gentile, S. (2010) · CNS Spectrums · doi:10.1017/s1092852900027449 · Cited by 53
Long-Term Outcomes of Developmental Exposure to Fluoxetine: A Review of the Animal Literature
Kiryanova, V., McAllister, B. B., & Dyck, R. H. (2013) · Developmental Neuroscience · doi:10.1159/000355709 · Cited by 55
Increased Aggression, Improved Spatial Memory, and Reduced Anxiety-Like Behaviour in Adult Male Mice Exposed to Fluoxetine Early in Life
Kiryanova, V., & Dyck, R. H. (2014) · Developmental Neuroscience · doi:10.1159/000363102 · Cited by 56
Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration’s Mini-Sentinel program
Andrade, S. E., Reichman, M. E., Mott, K., Pitts, M., Kieswetter, C., Dinatale, M., Stone, M. B., Popovic, J., Haffenreffer, K., & Toh, S. (2016) · Archives of Women's Mental Health · doi:10.1007/s00737-016-0637-1 · Cited by 50
Self-citation
La dépression de l’antepartum : prévalence, diagnostic, traitement
Chatillon, O., & EVEN, C. (2010) · L Encéphale · doi:10.1016/j.encep.2010.02.004 · Cited by 51
Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study
Bernard, N., Forest, J., Tarabulsy, G. M., Bujold, E., Bouvier, D., & Giguère, Y. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2285-8 · Cited by 49
Association of antidepressant medication use during pregnancy with intellectual disability in offspring
Viktorin, A., Uher, R., Kolevzon, A., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1727 · Cited by 45
Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort
Grzeskowiak, L. E., Morrison, J. L., Henriksen, T. B., Bech, B. H., Obel, C., Olsen, J., & Pedersen, L. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13611 · Cited by 48
Prevalence of antidepressant use and contacts with psychiatrists and psychologists in pregnant and postpartum women
Munk‐Olsen, T., Gasse, C., & Laursen, T. M. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01784.x · Cited by 48
Unplanned pregnancy and discontinuation of SSRIs in pregnant women with previously treated affective disorder
Roca, A., Imaz, M. L., Torres, A., Plaza, A., Subirà, S., Valdés, M., Martín‐Santos, R., & Garcia-Esteve, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.040 · Cited by 52
Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta‐analysis of cohort studies
Shen, Z., Gao, S., Li, S. X., Zhang, T., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X., Ji, C., et al. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13161 · Cited by 48
Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.
Johansen, R. L. R., Mortensen, L., Andersen, A., Hansen, A. V., & Strandberg-Larsen, K. (2015) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12160 · Cited by 45
Serotonin Transporter Occupancy in Rats Exposed to Serotonin Reuptake Inhibitors In Utero or via Breast Milk
Capello, C. F., Bourke, C. H., Ritchie, J., Stowe, Z. N., Newport, D. J., Nemeroff, A., & Owens, M. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183855 · Cited by 49
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis
Leshem, R., Bar‐Oz, B., Diav‐Citrin, O., Gbaly, S., Soliman, J., Renoux, C., & Matok, I. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210303121059 · Cited by 54
Serotonin system in the human placenta – the knowns and unknowns
Perić, M., Bečeheli, I., Čičin‐Šain, L., Desoyé, G., & Štefulj, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061317 · Cited by 49
Antidepressant medication use, depression, and the risk of preeclampsia
Avalos, L. A., Chen, H., & Li, D. (2015) · CNS Spectrums · doi:10.1017/s1092852915000024 · Cited by 46
Prenatal Antidepressant Use and Risk of Adverse Neonatal Outcomes
Bandoli, G., Chambers, C., Wells, A., & Palmsten, K. K. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2493 · Cited by 46
Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study
Grzeskowiak, L. E., McBain, R. D., Dekker, G., & Clifton, V. L. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13612 · Cited by 45
The clinical content of preconception care: women with psychiatric conditions
Frieder, A., Dunlop, A. L., Culpepper, L., & Bernstein, P. S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.001 · Cited by 49
The Ethics of Randomized Placebo-Controlled Trials of Antidepressants With Pregnant Women
Coverdale, J., McCullough, L. B., & Chervenak, F. A. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31818c2a27 · Cited by 45
The use of antidepressant medication in pregnancy
Ray, S. L., & Stowe, Z. N. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.09.005 · Cited by 47
Risk of Vaginal Bleeding and Postpartum Hemorrhage After Use of Antidepressants in Pregnancy
Lupattelli, A., Spigset, O., Koren, G., & Nordeng, H. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000036 · Cited by 44
In vivo and in vitro estrogenic activity of the antidepressant fluoxetine
Müller, J. C., Imazaki, P. H. D., Boareto, A. C., Lourenço, E. L. B., Penteado, M. G., Vechi, M. F., Lombardi, N. F., Minatovicz, B., Scippo, M., Martino‐Andrade, A. J., et al. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2012.04.001 · Cited by 44
Mediators of Adverse Birth Outcomes Among Socially Disadvantaged Women
Gavin, A. R., Nurius, P. S., & Logan‐Greene, P. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.2766 · Cited by 48
Maternal depression, antidepressant use in pregnancy and Apgar scores in infants
Jensen, H. M., Gr⊘n, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.115931 · Cited by 42
Determinants of brain-derived neurotrophic factor (BDNF) in umbilical cord and maternal serum
Flöck, A., Weber, S. K., Ferrari, N., Fietz, C., Graf, C., Fimmers, R., Gembruch, U., & Merz, W. M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.028 · Cited by 42
Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit
Thibeault, A.-A. H., Laurent, L., Duy, S. V., Sauvé, S., Caron, P., Guillemette, C., Sanderson, J. T., & Vaillancourt, C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.021 · Cited by 40
Female pelvic floor biomechanics
Easley, D. C., Abramowitch, S. D., & Moalli, P. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000380 · Cited by 41
Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study
Wallace, K. L., Martin, J. N., Jr., Tam, K. T., Wallukat, G., Dechend, R., LaMarca, B. B., & Owens, M. Y. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.01.049 · Cited by 40
Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy – an epidemiological study using validated EUROCAT data
Knudsen, T. M., Hansen, A. V., Garne, E., & Andersen, A. N. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-333 · Cited by 39
Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors
Videman, M., Tokariev, A., Saikkonen, H., Stjerna, S., Heiskala, H. J., Mantere, O., & Vanhatalo, S. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw153 · Cited by 39
Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age
Viktorin, A., Lichtenstein, P., Lundholm, C., Almqvist, C., D'Onofrio, B. M., Larsson, H., Landén, M., & Magnusson, P. K. E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv351 · Cited by 38
Antidepressant prescriptions for prenatal and postpartum women in Japan: A health administrative database study
Ishikawa, T., Obara, T., Kikuchi, S., Kobayashi, N., Miyakoda, K., Nishigori, H., Tomita, H., Akazawa, M., Yaegashi, N., Kuriyama, S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.016 · Cited by 41
Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data
Swanson, S. A., Hernández–Dı́az, S., Palmsten, K. K., Mogun, H., Olfson, M., & Huybrechts, K. F. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3798 · Cited by 37
Breastfeeding among Women Exposed to Antidepressants during Pregnancy
Gorman, J. R., Kao, K. K., & Chambers, C. (2012) · Journal of Human Lactation · doi:10.1177/0890334411429782 · Cited by 37
Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage
Palmsten, K. K., Chambers, C., Wells, A., & Bandoli, G. (2020) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12660 · Cited by 37
Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats
Bourke, C. H., Stowe, Z. N., Neigh, G. N., Olson, D. E., & Owens, M. J. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2013.07.008 · Cited by 37
The effects of antenatal depression and antidepressant treatment on placental gene expression
Olivier, J. D. A., Åkerud, H., Skalkidou, A., Kaihola, H., & Poromaa, I. S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00465 · Cited by 37
Prenatal Antidepressant Exposure: Clinical and Preclinical Findings
Bourke, C. H., Stowe, Z. N., & Owens, M. J. (2014) · Pharmacological Reviews · doi:10.1124/pr.111.005207 · Cited by 39
Preschool Outcomes Following Prenatal Serotonin Reuptake Inhibitor Exposure
Johnson, K. C., Smith, A. K., Stowe, Z. N., Newport, D. J., & Brennan, P. A. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09348 · Cited by 36
Gestational Exposure to Antidepressants and the Risk of Spontaneous Abortion: A Review
Broy, P., & Bérard, A. (2010) · Current Drug Delivery · doi:10.2174/156720110790396508 · Cited by 35
Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children
Boukhris, T., Sheehy, O., & Bérard, A. (2017) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12378 · Cited by 35
Citalopram and sertraline exposure compromises embryonic bone development
Fraher, D., Hodge, J., Collier, F., McMillan, J. S., Kennedy, R. L., Ellis, M. K., Nicholson, G., Walder, K., Dodd, S., Berk, M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.135 · Cited by 33
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
Diav‐Citrin, O., & Ornoy, A. (2011) · Obstetrics and Gynecology International · doi:10.1155/2012/698947 · Cited by 34
Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study
Poulton, A. S., Armstrong, B. K., & Nanan, R. K. H. (2018) · CNS Drugs · doi:10.1007/s40263-018-0505-9 · Cited by 35
Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes: A systematic review and meta-analyses of animal studies
Ramsteijn, A. S., de Wijer, L. V., Rando, J., van Luijk, J. A. K. R., Homberg, J. R., & Olivier, J. D. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.010 · Cited by 42
Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses
Uğuz, F. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1832080 · Cited by 33
Perinatal characteristics and risk of neuroblastoma
Johnson, K. J., Puumala, S. E., Soler, J. T., & Spector, L. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23645 · Cited by 34
Uterine Blood Flow in a Psychiatric Population: Impact of Maternal Depression, Anxiety, and Psychotropic Medication
Monk, C. E., Newport, D. J., Korotkin, J. H., Long, Q., Knight, B. T., & Stowe, Z. N. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.006 · Cited by 33
Infant neurodevelopment following in utero exposure to antidepressant medication
Austin, M., Karatas, J., Mishra, P., Christl, B., Kennedy, D. S., & Oei, J. L. (2013) · Acta Paediatrica · doi:10.1111/apa.12379 · Cited by 33
Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?
Ornoy, A., & Koren, G. (2017) · Birth Defects Research · doi:10.1002/bdr2.1078 · Cited by 32
In utero exposure to venlafaxine, a serotonin–norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat
Laurent, L., Huang, C., Ernest, S. R., Bérard, A., Vaillancourt, C., & Hales, B. F. (2016) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23537 · Cited by 34
Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes
Johnson, K. E., Beaton, S. J., Andrade, S. E., Cheetham, T. C., Scott, P. E., Hammad, T. A., Dashevsky, I., Cooper, W. O., Davis, R. L., Pawloski, P. A., et al. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3443 · Cited by 32
Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies
Zhang, T., Gao, S., Shen, Z., Li, D., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X. P., Ji, C., et al. (2017) · Scientific Reports · doi:10.1038/srep43085 · Cited by 32
Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2011) · Drug Safety · doi:10.2165/11593130-000000000-00000 · Cited by 31
Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: A case‐control study using a claims database in Japan
Ogawa, Y., Takeshima, N., & Furukawa, T. A. (2018) · Asia-Pacific Psychiatry · doi:10.1111/appy.12309 · Cited by 32
Sertraline exposure leads to small left heart syndrome in adult mice
Haskell, S. E., Hermann, G. M., Reinking, B. E., Volk, K. A., Peotta, V. A., Zhu, V. L., & Roghair, R. D. (2012) · Pediatric Research · doi:10.1038/pr.2012.183 · Cited by 31
Antenatal exposure to antidepressants is associated with altered brain development in very preterm-born neonates
Podrebarac, S. K., Duerden, E. G., Chau, V., GRUNAU, R. E., Synnes, A. R., Oberlander, T. F., & Miller, S. P. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.025 · Cited by 31
Antenatal depression and antidepressants during pregnancy: Unraveling the complex interactions for the offspring
Olivier, J. D. A., Åkerud, H., & Poromaa, I. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.049 · Cited by 30
Long term impact of prenatal exposure to SSRIs on growth and body weight in childhood: Evidence from animal and human studies
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2012.03.003 · Cited by 29
Use of Antidepressant Medication in the United States During Pregnancy, 2002–2010
Meunier, M. R., Bennett, I. M., & Coco, A. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200455 · Cited by 31
The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age
Jensen, H. M., Grøn, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3029-5 · Cited by 29
In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta‐analysis
Halvorsen, A., Hesel, B., Østergaard, S. D., & Danielsen, A. A. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13030 · Cited by 31
Variations of plasma D-dimer level at various points of normal pregnancy and its trends in complicated pregnancies
Baboolall, U., Zha, Y., Gong, X., Deng, D. R., Qiao, F., & Liu, H. (2019) · Medicine · doi:10.1097/md.0000000000015903 · Cited by 29
Commentary
Palmsten, K. K., & Hernández–Dı́az, S. (2012) · Epidemiology · doi:10.1097/ede.0b013e318258fbb2 · Cited by 29
Prenatal Selective Serotonin Reuptake Inhibitor Use and Associated Risk for Gestational Hypertension and Preeclampsia: A Meta-Analysis of Cohort Studies
Guan, H.-B., Yang, W., Wang, L., Qiao, C., & Liu, C. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6642 · Cited by 30
Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization
Clabault, H., Flipo, D., Guibourdenche, J., Fournier, T., Sanderson, J. T., & Vaillancourt, C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.04.018 · Cited by 30
Prenatal Antidepressant Exposure and Child Motor Development: A Meta-analysis
Grove, K., Lewis, A. J., & Galbally, M. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0356 · Cited by 29
Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure
Maloney, S. E., Akula, S. K., Rieger, M. A., McCullough, K. B., Chandler, K., Corbett, A. M., McGowin, A. E., & Dougherty, J. D. (2018) · eNeuro · doi:10.1523/eneuro.0120-18.2018 · Cited by 27
Trend of antidepressants before, during, and after pregnancy across two decades—A population‐based study
Sun, Y., Dreier, J. W., Liu, X., Ingstrup, K. G., Mægbæk, M. L., Munk‐Olsen, T., & Christensen, J. (2019) · Brain and Behavior · doi:10.1002/brb3.1441 · Cited by 28
How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?
Hurault‐Delarue, C., Chouquet, C., Savy, N., Lacroix, I., Beau, A., Montastruc, J., & Damase‐Michel, C. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4000 · Cited by 28
The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies
Tak, C. R., Job, K. M., Schoen-Gentry, K., Campbell, S. C., Carroll, P., Costantine, M., Brixner, D., Birnbaum, A. K., & Sherwin, C. M. T. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2269-4 · Cited by 27
Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial
Molenaar, N. M., Brouwer, M. E., Bockting, C., Bonsel, G. J., van der Veere, C. N., Torij, H. W., Hoogendijk, W. J. G., Duvekot, J. J., Burger, H., & den Berg, M. P. L. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0752-6 · Cited by 29
Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study
Heller, H. M., Ravelli, A. C. J., Bruning, A. H. L., de Groot, C. J. M., Scheele, F., van Pampus, M. G., & Honig, A. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1334-4 · Cited by 27
Recurrent Neural Networks in Medical Data Analysis and Classifications
Alaskar, H., Radi, N., & MacDermott, Á. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803468-2.00007-2 · Cited by 27
Perinatal Outcomes of Pregnancies Complicated by Maternal Depression with or without Selective Serotonin Reuptake Inhibitor Therapy
Engelstad, H. J., Roghair, R. D., Calarge, C. A., Colaizy, T. T., Stuart, S. P., & Haskell, S. E. (2013) · Neonatology · doi:10.1159/000356774 · Cited by 27
Child developmental outcomes in preschool children following antidepressant exposure in pregnancy
Galbally, M., Lewis, A. J., & Buist, A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415569800 · Cited by 27
SSRI use during pregnancy
Tran, H., & Robb, A. S. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.08.010 · Cited by 26
Effect of sertraline on central serotonin and hippocampal plasticity in pregnant and non-pregnant rats
Pawluski, J. L., Paravatou, R., Even, A., Cobraiville, G., Fillet, M., Kokras, N., Dalla, C., & Charlier, T. D. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107950 · Cited by 26
Primary care physician’s attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries
Bilszta, J. L. C., Tsuchiya, S., Han, K., Buist, A., & Einarson, A. (2010) · Archives of Women s Mental Health · doi:10.1007/s00737-010-0197-8 · Cited by 27
Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy
Grossman, K. B., Arya, R., Peixoto, A. B., Akolekar, R., STABOULIDOU, I., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.05.013 · Cited by 26
Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy
Ocampo, M. P. G. D., Araneta, M. R. G., Macera, C. A., Alcaraz, J. E., Moore, T. R., & Chambers, C. (2016) · Archives of Women s Mental Health · doi:10.1007/s00737-016-0655-z · Cited by 26
Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
Malm, H. T., Artama, M., Brown, A. S., Gissler, M., Gyllenberg, D., Hinkka‐Yli‐Salomäki, S., McKeague, I. W., & Sourander, A. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-217 · Cited by 25
Prenatal Exposure to Selective Serotonin Reuptake Inhibitors and Infant Outcome
Malm, H. T. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31826d07ea · Cited by 25
Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age
Grzeskowiak, L. E., Gilbert, A. L., Sørensen, T. I. A., Olsen, J., Sørensen, H. T., Pedersen, L. H., & Morrison, J. L. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.08.005 · Cited by 24
Antidepressant Use During Pregnancy and Asthma in the Offspring
Liu, X., Olsen, J., Pedersen, L. H., Agerbo, E., Yuan, W., & Li, J. (2015) · PEDIATRICS · doi:10.1542/peds.2014-4073 · Cited by 24
The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness
Frayne, J. S., Nguyen, T., Bennett, K., Allen, S., Hauck, Y. L., & Liira, H. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12621 · Cited by 24
Antidepressants induce toxicity in human placental BeWo cells
Nabekura, T., Ishikawa, S., Tanase, M., Okumura, T., & Kawasaki, T. (2022) · Current Research in Toxicology · doi:10.1016/j.crtox.2022.100073 · Cited by 23
Postpartum thrombotic microangiopathic syndrome
Owens, M. Y., Martin, J. N., Jr., Wallace, K. L., Keiser, S., Parrish, M. R., Tam, K. B. T., & Martin, R. W. (2012) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2012.05.016 · Cited by 24
Pregnancy Exposure to Serotonin Reuptake Inhibitors and the Risk of Spontaneous Abortions
Gentile, S. (2008) · CNS Spectrums · doi:10.1017/s1092852900014012 · Cited by 24
Longitudinal trajectories of antidepressant use in pregnancy and the postnatal period
Bandoli, G., Kuo, G. M., Sugathan, R., Chambers, C., Rolland, M., & Palmsten, K. (2018) · Archives of Women's Mental Health · doi:10.1007/s00737-018-0809-2 · Cited by 24
Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats
Long, N. E. D., Barry, E. J., Pinelli, C. J., Wood, G. A., Hardy, D. B., Morrison, K. M., Taylor, V. H., Gerstein, H. C., & Holloway, A. C. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.006 · Cited by 24
Is it safe to use smoking cessation therapeutics during pregnancy?
Long, N. E. D., Barra, N. G., Hardy, D. B., & Holloway, A. C. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.973846 · Cited by 23
Selective serotonin reuptake inhibitors in pregnancy and infant outcomes
Jefferies, A. L. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.9.562 · Cited by 23
In Utero and Lactational Exposure to Fluoxetine in Wistar Rats: Pregnancy Outcomes and Sexual Development
Müller, J. C., Boareto, A. C., Lourenço, E. L. B., Zaia, R. M., Kienast, M. F., Spercoski, K. M., de Morais, R. N., Martino‐Andrade, A. J., & Dalsenter, P. R. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12072 · Cited by 26
The relationship between physical activity and mood across the perinatal period: A review of naturalistic and clinical research to guide future investigation of physical activity–based interventions for perinatal depression.
Davis, K., & Dimidjian, S. (2012) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2012.01273.x · Cited by 27
Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden
Ankarfeldt, M. Z., Petersen, J., Andersen, J. T., Li, H., Motsko, S. P., Fast, T., Hede, S. M., & Jimenez‐Solem, E. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003851 · Cited by 22

Authors: Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S. J., Roblin, D., Smith, D. H., Willy, M. E., Staffa, J. A., & Platt, R.
Affiliations: University of Massachusetts Chan Medical School (US)
Kaiser Permanente (US)
Harvard University (US)
Group Health Cooperative (US)
HealthPartners (US)
United States Food and Drug Administration (US)
Corresponding author: Andrade, Susan E.
ORCID: Andrade, Susan E.
Raebel, Marsha A.
Brown, Jeffrey
Boudreau, Denise
Smith, David H.
Staffa, Judy A.
Platt, Richard
Venue: American Journal of Obstetrics and Gynecology
Publisher: Elsevier BV
Published: 2008-02
Volume: 198
Issue: 2
Pages: 194.e1-194.e5
ISSN: 0002-9378 (ISSN-L)
DOI: 10.1016/j.ajog.2007.07.036
OpenAlex: W2063638540
Cited by: 403
References: 18
Citations by year: 2026: 1 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 17 · 2021: 9 · 2020: 24 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 38 · 2015: 37 · 2014: 28 · 2013: 43 · 2012: 39
FWCI: 15.45
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: American Journal of Obstetrics and Gynecology (publishedVersion)
PubMed (publishedVersion)
The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords: antidepressant use in pregnancy, selective serotonin reuptake inhibitors, maternal mental health, prenatal drug exposure, health insurance claims
MeSH terms: Adolescent, Adult, Antidepressive Agents, Depressive Disorder, Female, Health Maintenance Organizations, Humans, Infant, Newborn, Middle Aged, Practice Patterns, Physicians', Pregnancy, Pregnancy Complications, Prenatal Care, Retrospective Studies, United States, Databases, Factual, Selective Serotonin Reuptake Inhibitors, Drug Utilization Review

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Use of antidepressant medications during pregnancy: a multisite study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks